Equity Overview
Price & Market Data
Price: $0.50
Daily Change: $0.00 / 0.00%
Range: $0.50 - $0.508
Market Cap: $39,003,952
Volume: 2,432
Performance Metrics
1 Week: 4.17%
1 Month: 2.25%
3 Months: 26.73%
6 Months: 4.17%
1 Year: 6.38%
YTD: 10.06%
Company Details
Employees: 17
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.